Hemophagocytic Lymphohistiocytosis clinical trials

Explore recruiting hemophagocytic lymphohistiocytosis clinical trials.

Recruiting hemophagocytic lymphohistiocytosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hemophagocytic Lymphohistiocytosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Application of antiCD19 CAR T lymphocytes for the treatment of adult patients with B-cell acute lymphoblastic leukemia with resistance, relapse or detectable measurable residual disease. Phase I/II clinical trial (MERMAID1)

Poland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: a randomized trial »

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

MUNC13.4 - A phase I/II Open Label non randomized study, monocentric, single arm, evaluating Safety and Efficacy of Gene Therapy of FHL 3 caused by mutations in the human UNC13D gene by transplantation of a single dose of autologous CD34+ cells transduced ex vivo with the UNC13D LV vector expressing the UNC13D cDNA

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: a randomized trial »

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3, Open-label, Single-arm, Multicenter, Historical Control Study to Evaluate ELA026 in Participants with Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

Germany, Spain, Italy, Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase II study evaluating efficacy of KTE-X19 CAR-T cell therapy in Relapsed or Refractory Mantle-Cell Lymphoma achieving a partial response during Ibrutinib salvage therapy

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Hemophagocytic Lymphohistiocytosis trials by city

Hemophagocytic Lymphohistiocytosis in Toronto Hemophagocytic Lymphohistiocytosis in Vancouver Hemophagocytic Lymphohistiocytosis in Montreal Hemophagocytic Lymphohistiocytosis in Calgary Hemophagocytic Lymphohistiocytosis in Edmonton Hemophagocytic Lymphohistiocytosis in Ottawa Hemophagocytic Lymphohistiocytosis in Winnipeg Hemophagocytic Lymphohistiocytosis in Quebec City Hemophagocytic Lymphohistiocytosis in Hamilton Hemophagocytic Lymphohistiocytosis in Kitchener Hemophagocytic Lymphohistiocytosis in London Hemophagocytic Lymphohistiocytosis in Halifax Hemophagocytic Lymphohistiocytosis in New York Hemophagocytic Lymphohistiocytosis in Los Angeles Hemophagocytic Lymphohistiocytosis in Chicago Hemophagocytic Lymphohistiocytosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease